7 results
Use of iron chelation therapy has demonstrated benefits in terms of morbidity and mortality for chronically-transfused thalassemia patients with iron overload. Recent retrospective data (Leitch 2007, Rose 2010, Sanz 2008) suggest that overall…
The objective of this prospective, observational study is to ensure the safety and the wellbeing of subjects treated with the NEVO* SES.
The primary objective of the study is to determine concentration of circulation cytokines na administration of LPS in the presence of iron sucrose (Venofer®), Deferasirox (Exjade®) of placebo.
Nemo Healthcare B.V. recently developed a new technique for monitoring the unborn baby. This technique is already widely used in unborn babies over 37 weeks of gestational age. The purpose of this study is to examine if that new technique is also…
The novel mouldable peristomal adhesive (Provox Life FreeHands Adhesive) can be modelled to the patient*s neck and stoma shape when warmed, and remains its shape when cooled. The hypothesis is that this mouldable peristomal adhesive will improve the…
To study the safety and efficacy of deferasirox as treatment of oxidative stress in adult subjects with sickle cell disease.
To determine the workability of the non-invasive abdominal electrode patch for implementation in clinical practice.